Concepts (184)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Oxidative Stress | 12 | 2025 | 239 | 3.020 |
Why?
|
| Muscle, Skeletal | 12 | 2026 | 524 | 2.030 |
Why?
|
| Diaphragm | 11 | 2020 | 38 | 1.940 |
Why?
|
| Muscle Contraction | 5 | 2024 | 113 | 1.830 |
Why?
|
| Mitochondria | 8 | 2025 | 206 | 1.350 |
Why?
|
| Aging | 5 | 2026 | 938 | 1.090 |
Why?
|
| Sarcopenia | 3 | 2024 | 66 | 1.040 |
Why?
|
| Genital Neoplasms, Female | 1 | 2025 | 26 | 0.930 |
Why?
|
| Reactive Oxygen Species | 7 | 2024 | 163 | 0.920 |
Why?
|
| Resilience, Psychological | 1 | 2025 | 20 | 0.910 |
Why?
|
| Mice | 20 | 2025 | 2511 | 0.900 |
Why?
|
| Disease Models, Animal | 10 | 2024 | 1012 | 0.900 |
Why?
|
| Longevity | 2 | 2024 | 21 | 0.880 |
Why?
|
| Ghrelin | 1 | 2024 | 3 | 0.880 |
Why?
|
| Muscular Atrophy | 4 | 2020 | 76 | 0.880 |
Why?
|
| Energy Metabolism | 1 | 2025 | 155 | 0.860 |
Why?
|
| Animals | 27 | 2025 | 7569 | 0.790 |
Why?
|
| Mice, Knockout | 11 | 2025 | 453 | 0.740 |
Why?
|
| Systole | 1 | 2021 | 98 | 0.680 |
Why?
|
| Mice, Inbred C57BL | 8 | 2025 | 789 | 0.640 |
Why?
|
| Myocardium | 1 | 2021 | 191 | 0.630 |
Why?
|
| Free Radicals | 1 | 2019 | 9 | 0.620 |
Why?
|
| Molecular Imaging | 1 | 2019 | 20 | 0.610 |
Why?
|
| Muscle Weakness | 5 | 2020 | 36 | 0.600 |
Why?
|
| Oxidation-Reduction | 6 | 2021 | 267 | 0.600 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2018 | 11 | 0.560 |
Why?
|
| Oxygen Consumption | 3 | 2023 | 150 | 0.550 |
Why?
|
| Heart Failure | 3 | 2019 | 695 | 0.460 |
Why?
|
| Phrenic Nerve | 1 | 2014 | 5 | 0.450 |
Why?
|
| Respiration, Artificial | 3 | 2020 | 98 | 0.440 |
Why?
|
| Intraoperative Care | 1 | 2014 | 48 | 0.440 |
Why?
|
| Electric Stimulation | 1 | 2014 | 106 | 0.430 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2014 | 81 | 0.410 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2019 | 1307 | 0.410 |
Why?
|
| Hypertension, Pulmonary | 1 | 2013 | 24 | 0.400 |
Why?
|
| Cachexia | 3 | 2020 | 8 | 0.370 |
Why?
|
| Physical Fitness | 1 | 2013 | 133 | 0.370 |
Why?
|
| Male | 16 | 2026 | 19641 | 0.360 |
Why?
|
| Superoxide Dismutase | 3 | 2021 | 42 | 0.360 |
Why?
|
| Adiposity | 1 | 2013 | 198 | 0.350 |
Why?
|
| Insulin Resistance | 1 | 2013 | 469 | 0.310 |
Why?
|
| Postoperative Complications | 1 | 2014 | 828 | 0.300 |
Why?
|
| Phosphorylation | 2 | 2021 | 226 | 0.280 |
Why?
|
| Humans | 14 | 2026 | 32798 | 0.280 |
Why?
|
| Physical Conditioning, Animal | 2 | 2018 | 35 | 0.270 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 3 | 2025 | 10 | 0.270 |
Why?
|
| Female | 11 | 2026 | 20261 | 0.270 |
Why?
|
| Sphingomyelin Phosphodiesterase | 2 | 2019 | 5 | 0.260 |
Why?
|
| Muscle Fibers, Skeletal | 2 | 2026 | 107 | 0.250 |
Why?
|
| Muscular Diseases | 1 | 2025 | 23 | 0.240 |
Why?
|
| Autophagy | 1 | 2025 | 55 | 0.230 |
Why?
|
| Calcium | 3 | 2025 | 323 | 0.230 |
Why?
|
| Acylation | 1 | 2024 | 1 | 0.220 |
Why?
|
| Atrophy | 4 | 2020 | 46 | 0.210 |
Why?
|
| Pilot Projects | 1 | 2025 | 565 | 0.200 |
Why?
|
| Genome, Mitochondrial | 1 | 2023 | 2 | 0.200 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2021 | 79 | 0.200 |
Why?
|
| Methamphetamine | 1 | 2023 | 19 | 0.200 |
Why?
|
| Reperfusion Injury | 1 | 2023 | 57 | 0.190 |
Why?
|
| Rats | 6 | 2023 | 1606 | 0.180 |
Why?
|
| Ribosomes | 1 | 2021 | 10 | 0.170 |
Why?
|
| Ribosomal Proteins | 1 | 2021 | 6 | 0.170 |
Why?
|
| Hypertrophy | 1 | 2021 | 29 | 0.170 |
Why?
|
| Troponin I | 1 | 2021 | 21 | 0.170 |
Why?
|
| STAT3 Transcription Factor | 1 | 2021 | 23 | 0.170 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2021 | 34 | 0.170 |
Why?
|
| Aminoquinolines | 1 | 2020 | 17 | 0.170 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2021 | 71 | 0.170 |
Why?
|
| Carcinoma, Lewis Lung | 1 | 2020 | 3 | 0.170 |
Why?
|
| Benzamides | 1 | 2020 | 54 | 0.170 |
Why?
|
| Copper | 1 | 2020 | 11 | 0.170 |
Why?
|
| Antioxidants | 3 | 2024 | 115 | 0.170 |
Why?
|
| Fibrosis | 1 | 2021 | 122 | 0.170 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 1 | 2020 | 65 | 0.170 |
Why?
|
| Organ Size | 1 | 2021 | 219 | 0.160 |
Why?
|
| Motor Neurons | 1 | 2020 | 40 | 0.160 |
Why?
|
| Zinc | 1 | 2020 | 31 | 0.160 |
Why?
|
| Signal Transduction | 2 | 2021 | 686 | 0.150 |
Why?
|
| HSP72 Heat-Shock Proteins | 1 | 2019 | 1 | 0.150 |
Why?
|
| Neuroprotective Agents | 1 | 2019 | 27 | 0.150 |
Why?
|
| Kidney Transplantation | 1 | 2023 | 512 | 0.150 |
Why?
|
| PPAR alpha | 1 | 2019 | 29 | 0.150 |
Why?
|
| Mice, Transgenic | 2 | 2024 | 258 | 0.150 |
Why?
|
| Excitation Contraction Coupling | 1 | 2018 | 8 | 0.140 |
Why?
|
| RNA, Small Interfering | 1 | 2019 | 113 | 0.140 |
Why?
|
| Diabetic Retinopathy | 1 | 2019 | 73 | 0.140 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 1 | 2017 | 10 | 0.130 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2019 | 265 | 0.130 |
Why?
|
| Physical Endurance | 1 | 2017 | 35 | 0.130 |
Why?
|
| Proteome | 1 | 2017 | 40 | 0.130 |
Why?
|
| Stroke Volume | 2 | 2019 | 370 | 0.120 |
Why?
|
| Proteomics | 1 | 2017 | 97 | 0.120 |
Why?
|
| Body Weight | 2 | 2018 | 301 | 0.120 |
Why?
|
| Aged | 2 | 2026 | 10538 | 0.120 |
Why?
|
| Echocardiography | 1 | 2015 | 182 | 0.110 |
Why?
|
| Coronary Vessels | 1 | 2015 | 164 | 0.110 |
Why?
|
| RNA, Messenger | 1 | 2015 | 498 | 0.100 |
Why?
|
| Exercise | 1 | 2019 | 679 | 0.100 |
Why?
|
| Monocrotaline | 1 | 2013 | 2 | 0.100 |
Why?
|
| Neoplasms, Experimental | 1 | 2013 | 30 | 0.100 |
Why?
|
| Skinfold Thickness | 1 | 2013 | 7 | 0.100 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2013 | 20 | 0.100 |
Why?
|
| Chronic Disease | 1 | 2024 | 410 | 0.100 |
Why?
|
| Eating | 1 | 2013 | 74 | 0.100 |
Why?
|
| Colonic Neoplasms | 1 | 2013 | 74 | 0.100 |
Why?
|
| Homeostasis | 1 | 2013 | 135 | 0.090 |
Why?
|
| Respiratory Insufficiency | 1 | 2013 | 59 | 0.090 |
Why?
|
| Analysis of Variance | 1 | 2013 | 459 | 0.090 |
Why?
|
| Regeneration | 1 | 2013 | 170 | 0.090 |
Why?
|
| Alzheimer Disease | 1 | 2024 | 302 | 0.090 |
Why?
|
| Myocardial Infarction | 1 | 2015 | 483 | 0.090 |
Why?
|
| Sex Factors | 1 | 2013 | 675 | 0.090 |
Why?
|
| Blotting, Western | 3 | 2017 | 287 | 0.080 |
Why?
|
| Glutathione | 2 | 2023 | 45 | 0.080 |
Why?
|
| Enzyme Activation | 2 | 2020 | 133 | 0.080 |
Why?
|
| Inflammation | 1 | 2013 | 536 | 0.080 |
Why?
|
| Rats, Wistar | 2 | 2019 | 79 | 0.070 |
Why?
|
| Phenotype | 2 | 2020 | 638 | 0.060 |
Why?
|
| Child | 1 | 2013 | 2478 | 0.060 |
Why?
|
| Entropy | 1 | 2026 | 7 | 0.060 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2019 | 754 | 0.060 |
Why?
|
| Muscle Proteins | 2 | 2017 | 63 | 0.060 |
Why?
|
| Gene Expression | 2 | 2018 | 334 | 0.060 |
Why?
|
| Adolescent | 1 | 2013 | 3638 | 0.060 |
Why?
|
| Rats, Inbred WKY | 1 | 2023 | 19 | 0.050 |
Why?
|
| Rats, Inbred Strains | 1 | 2023 | 47 | 0.050 |
Why?
|
| Rats, Inbred Lew | 1 | 2023 | 120 | 0.050 |
Why?
|
| Rats, Inbred F344 | 1 | 2023 | 134 | 0.050 |
Why?
|
| Swine | 1 | 2023 | 216 | 0.050 |
Why?
|
| Corpus Striatum | 1 | 2023 | 62 | 0.050 |
Why?
|
| Estradiol | 1 | 2023 | 121 | 0.050 |
Why?
|
| Ventilators, Mechanical | 1 | 2020 | 6 | 0.040 |
Why?
|
| Injections, Intraperitoneal | 1 | 2020 | 47 | 0.040 |
Why?
|
| Cell Line, Tumor | 2 | 2013 | 726 | 0.040 |
Why?
|
| Mitochondria, Muscle | 1 | 2020 | 17 | 0.040 |
Why?
|
| MAP Kinase Signaling System | 1 | 2020 | 65 | 0.040 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2020 | 64 | 0.040 |
Why?
|
| Tetrazoles | 1 | 2020 | 63 | 0.040 |
Why?
|
| Imidazoles | 1 | 2020 | 92 | 0.040 |
Why?
|
| Middle Aged | 1 | 2014 | 12125 | 0.040 |
Why?
|
| Dopamine | 1 | 2023 | 234 | 0.040 |
Why?
|
| Kidney | 1 | 2023 | 520 | 0.040 |
Why?
|
| Benzylidene Compounds | 1 | 2019 | 6 | 0.040 |
Why?
|
| Aniline Compounds | 1 | 2019 | 18 | 0.040 |
Why?
|
| Rats, Inbred BN | 1 | 2019 | 32 | 0.040 |
Why?
|
| Glutathione Reductase | 1 | 2018 | 9 | 0.040 |
Why?
|
| Retinal Diseases | 1 | 2019 | 25 | 0.040 |
Why?
|
| Intracellular Space | 1 | 2018 | 16 | 0.040 |
Why?
|
| Retina | 1 | 2019 | 84 | 0.040 |
Why?
|
| Aged, 80 and over | 1 | 2026 | 4032 | 0.040 |
Why?
|
| Calcium Signaling | 1 | 2018 | 46 | 0.030 |
Why?
|
| Age Factors | 1 | 2020 | 1197 | 0.030 |
Why?
|
| Neurons | 1 | 2021 | 416 | 0.030 |
Why?
|
| Cytosol | 1 | 2017 | 22 | 0.030 |
Why?
|
| Subcellular Fractions | 1 | 2017 | 15 | 0.030 |
Why?
|
| Solubility | 1 | 2017 | 38 | 0.030 |
Why?
|
| Apoptosis | 1 | 2019 | 362 | 0.030 |
Why?
|
| Kinetics | 1 | 2017 | 205 | 0.030 |
Why?
|
| Mitochondrial Proteins | 1 | 2017 | 71 | 0.030 |
Why?
|
| Reactive Nitrogen Species | 1 | 2016 | 5 | 0.030 |
Why?
|
| Electron Transport Complex IV | 1 | 2016 | 3 | 0.030 |
Why?
|
| Glutathione Peroxidase | 1 | 2016 | 10 | 0.030 |
Why?
|
| Superoxides | 1 | 2016 | 19 | 0.030 |
Why?
|
| Calpain | 1 | 2016 | 13 | 0.030 |
Why?
|
| Hydrogen Peroxide | 1 | 2016 | 84 | 0.030 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2016 | 168 | 0.030 |
Why?
|
| Muscle Fatigue | 1 | 2013 | 12 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2019 | 2327 | 0.030 |
Why?
|
| SKP Cullin F-Box Protein Ligases | 1 | 2013 | 3 | 0.030 |
Why?
|
| Tropomyosin | 1 | 2013 | 3 | 0.030 |
Why?
|
| Muscle Fibers, Slow-Twitch | 1 | 2013 | 19 | 0.030 |
Why?
|
| Respiratory Muscles | 1 | 2013 | 5 | 0.030 |
Why?
|
| Muscle Fibers, Fast-Twitch | 1 | 2013 | 28 | 0.020 |
Why?
|
| Actins | 1 | 2013 | 51 | 0.020 |
Why?
|
| Extremities | 1 | 2013 | 54 | 0.020 |
Why?
|
| Muscle Development | 1 | 2013 | 49 | 0.020 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2013 | 43 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 255 | 0.020 |
Why?
|
| Myosin Heavy Chains | 1 | 2013 | 89 | 0.020 |
Why?
|
| Calcinosis | 1 | 2013 | 146 | 0.020 |
Why?
|
| Troponin | 1 | 2013 | 109 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2013 | 497 | 0.020 |
Why?
|
| Macrophages | 1 | 2013 | 194 | 0.020 |
Why?
|
| Time Factors | 1 | 2013 | 2183 | 0.020 |
Why?
|